ELAN - Company ID 0001739104
The table below shows Elanco Animal Health Inc's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $4.71B | $4.44B | $4.42B | $4.41B | $4.76B | $3.27B |
| Cost of revenue | $2.12B | $2.00B | $1.93B | $1.91B | $2.13B | $1.67B |
| Gross profit | $2.59B | $2.44B | $2.49B | - | - | - |
| R&D | $368.00M | $344.00M | $327.00M | $321.00M | $369.00M | $329.00M |
Elanco Animal Health Inc reported annual revenue of $4.71B for fiscal year 2025. That is up 6.2% from $4.44B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $2.91B (FY 2016) to $4.71B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $1.43B |
| $1.31B |
| $1.28B |
| $1.26B |
| $1.40B |
| $997.00M |
| Operating income | - | - | - | - | - | - |
| Income tax | $8.00M | $150.00M | $36.00M | $6.00M | -$88.00M | -$103.00M |
| Net income | -$232.00M | $338.00M | -$1.23B | -$78.00M | -$483.00M | -$574.00M |
| EPS (diluted) | -$0.47 | $0.68 | -$2.50 | -$0.16 | -$0.99 | -$1.30 |